The relationships between chronic pain and changes in health with cannabis consumption patterns.
Cannabis
Cannabis consumption
Chronic-pain
Journal
The International journal on drug policy
ISSN: 1873-4758
Titre abrégé: Int J Drug Policy
Pays: Netherlands
ID NLM: 9014759
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
01
07
2019
revised:
18
12
2019
accepted:
29
12
2019
pubmed:
14
1
2020
medline:
29
7
2021
entrez:
14
1
2020
Statut:
ppublish
Résumé
Pain is the most common reason endorsed by patients seeking medical cannabis. Given the nature of chronic pain, it is particularly important to understand consumption patterns for patients who use cannabis for chronic health conditions to evaluate how frequency of use might impact overall health and functioning. This analysis examines whether levels of chronic pain were associated with cannabis consumption patterns, after controlling for patient-level differences in demographics. Our sample included 295 medical cannabis patients. Logistic regression models were fit to evaluate the association between pain (low, moderate and high) and dichotomous measures of cannabis consumption (daily vs. nondaily; ≥3 times per day vs. <3 times per day). Additionally, two ordered logit models were fit to evaluate the association between past-year health status change (better, same, or worse) and cannabis consumption. A significantly higher proportion of respondents in the high pain category used cannabis 3 or more times per day, compared to lower pain categories. Pain level was not significantly associated with daily cannabis use. However, pain level was significantly associated with log odds of using cannabis ≥3 times per day, such that respondents with both high pain and moderate pain had significantly higher log odds of consuming cannabis ≥3 times per day compared to low pain group. While the efficacy of cannabis for various medical conditions continues to be evaluated, the best available evidence suggests a possible benefit for the treatment of chronic pain. The results of this study indicate that individuals with high pain are more likely to consume cannabis multiple times a day, but this use may not be related to better health. Our results point to a need for more research on the health impacts of frequency of cannabis use among medical cannabis dispensary patients.
Sections du résumé
BACKGROUND
Pain is the most common reason endorsed by patients seeking medical cannabis. Given the nature of chronic pain, it is particularly important to understand consumption patterns for patients who use cannabis for chronic health conditions to evaluate how frequency of use might impact overall health and functioning. This analysis examines whether levels of chronic pain were associated with cannabis consumption patterns, after controlling for patient-level differences in demographics.
METHODS
Our sample included 295 medical cannabis patients. Logistic regression models were fit to evaluate the association between pain (low, moderate and high) and dichotomous measures of cannabis consumption (daily vs. nondaily; ≥3 times per day vs. <3 times per day). Additionally, two ordered logit models were fit to evaluate the association between past-year health status change (better, same, or worse) and cannabis consumption.
RESULTS
A significantly higher proportion of respondents in the high pain category used cannabis 3 or more times per day, compared to lower pain categories. Pain level was not significantly associated with daily cannabis use. However, pain level was significantly associated with log odds of using cannabis ≥3 times per day, such that respondents with both high pain and moderate pain had significantly higher log odds of consuming cannabis ≥3 times per day compared to low pain group.
CONCLUSION
While the efficacy of cannabis for various medical conditions continues to be evaluated, the best available evidence suggests a possible benefit for the treatment of chronic pain. The results of this study indicate that individuals with high pain are more likely to consume cannabis multiple times a day, but this use may not be related to better health. Our results point to a need for more research on the health impacts of frequency of cannabis use among medical cannabis dispensary patients.
Identifiants
pubmed: 31931439
pii: S0955-3959(19)30370-6
doi: 10.1016/j.drugpo.2019.102657
pmc: PMC7075439
mid: NIHMS1569367
pii:
doi:
Substances chimiques
Hallucinogens
0
Medical Marijuana
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
102657Subventions
Organisme : NICHD NIH HHS
ID : P2C HD041022
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA032715
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA007250
Pays : United States
Organisme : NICHD NIH HHS
ID : T32 HD007545
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Références
J Pain. 2015 Dec;16(12):1233-1242
pubmed: 26385201
Drug Alcohol Depend. 2017 Feb 01;171:70-83
pubmed: 28024188
Drug Alcohol Depend. 2013 Oct 1;132(3):654-9
pubmed: 23683791
Drug Test Anal. 2014 Jan-Feb;6(1-2):39-45
pubmed: 23836598
J Am Board Fam Med. 2013 Jan-Feb;26(1):52-60
pubmed: 23288281
Cannabis Cannabinoid Res. 2017 May 01;2(1):96-104
pubmed: 28861509
Am J Public Health. 2017 Aug;107(8):e1-e12
pubmed: 28644037
Lancet. 2011 Jun 25;377(9784):2226-35
pubmed: 21704872
Spine (Phila Pa 1976). 2000 Dec 15;25(24):3130-9
pubmed: 11124729
J Gen Intern Med. 2011 Nov;26(11):1364-7
pubmed: 21863349
Hawaii J Med Public Health. 2014 Apr;73(4):109-11
pubmed: 24765558
J Opioid Manag. 2009 Sep-Oct;5(5):257-86
pubmed: 19947069
Curr Rheumatol Rep. 2017 Oct 5;19(11):67
pubmed: 28983880
Lancet Public Health. 2018 Jul;3(7):e341-e350
pubmed: 29976328
Ann Intern Med. 2007 Oct 2;147(7):492-504
pubmed: 17909210
J Psychoactive Drugs. 2017 Jan-Mar;49(1):31-38
pubmed: 28001910
Eur J Pain. 2010 Feb;14(2):127.e1-8
pubmed: 19473857
Am J Drug Alcohol Abuse. 2015 Mar;41(2):166-72
pubmed: 25375878
Pain. 2003 Mar;102(1-2):211-6
pubmed: 12620613
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
J Psychoactive Drugs. 2016 Jan-Mar;48(1):56-62
pubmed: 26882461
Cannabis Cannabinoid Res. 2017 Jun 01;2(1):160-166
pubmed: 28861516
J Pain. 2016 Jun;17(6):739-44
pubmed: 27001005
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jul 13;93:284-290
pubmed: 31004724
Psychosom Med. 2015 Apr;77(3):333-41
pubmed: 25849129
J Pain. 2012 Feb;13(2):121-30
pubmed: 22099608